STEPHANIE KUNZ: Open Payments
NPI 1316552979 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 15 payments from 9 companies in 2025. Trend: 2023 $658 · 2024 $662 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $144 |
| PFIZER INC. | 4 | $79 |
| Baxter Healthcare | 1 | $52 |
| Abbott Laboratories | 2 | $42 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: ELIQUIS, Hillrom - Cardiac Ambulatory Monitor, GALLANT, AVEIR, FUROSCIX, FARXIGA, Repatha, JARDIANCE.
Industry payments across AL — which companies pay providers there.
